Robert Lechleider - Oct 27, 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Chief Medical Officer
Signature
/s/ Sandra G. Stoneman, Attorney-in-fact
Stock symbol
IMNM
Transactions as of
Oct 27, 2023
Transactions value $
$0
Form type
4
Date filed
10/31/2023, 06:30 PM
Previous filing
Oct 20, 2023
Next filing
Aug 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +400K $0.00 400K Oct 27, 2023 Common Stock 400K $8.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on October 16, 2024, and the remaining shares will vest monthly thereafter over three years.